Life Sciences



With one of America's highest concentrations of scientists and engineers, Connecticut has become a nucleus of bioscience advances — from groundbreaking research in personalized medicine to device manufacturing of the latest medical technology. Strong R&D partnerships with our universities are helping to speed the progress to new cures and advanced treatment protocols. It’s just one more reason that so many bioscience innovators find Connecticut a supportive environment for growth.

Key Advantages

See why bioscience companies of all sizes and all stages are taking maximum advantage of Connecticut’s dynamic intersection of intellectual capital and practical expertise.

  • A heritage of, and passion for, innovation. From the artificial heart to stem cell study to genome research, Connecticut continues to demonstrate its commitment to serving as a center for biomedical advances.
  • High-level talent pool. Connecticut’s educated, highly skilled workforce includes groundbreaking researchers, data-savvy providers, pharmaceutical pioneers and global leaders in medical technology.
  • Significant public and private investment. The state’s Bioscience Connecticut Initiative invested $1 billion to expand the University of Connecticut’s Health Center and to develop the Jackson Laboratory Genome Research Facility.
  • Commitment to growth. By 2037, Bioscience Connecticut is projected to create more than 16,000 new permanent jobs and generate additional personal income of $4.6 billion.

Targeted Support

Here are a few examples of the technical support, tax incentives and business development services available for bioscience companies. Click on any of the links below to learn more. Just be sure to also explore the rest of our site for the other programs available to all types of businesses.





Industry Leaders

Just a few of our key bioscience, healthcare and medical device leaders highlighted below:

You can also hear from a few of our sector leaders here.

Craig Crews

 Arvinas Founder Craig Crews on launching a pharmaceutical enterprise in New Haven.

Martin Mackay

 Alexion Pharmaceuticals global head of R&D, Martin Mackay, Ph.D., on CT's business assets.


For more information on the advantages of relocating or growing your Bioscience, Healthcare or Medical Device business here in Connecticut, please contact Pat Gillanders at (860) 500-2419, or